Chapman Paul W.d. - Net Worth and Insider Trading

Chapman Paul W.d. Net Worth

The estimated net worth of Chapman Paul W.d. is at least $15 dollars as of 2024-09-20. Chapman Paul W.d. is the COO of Millendo Therapeutics Inc and owns about 14 shares of Millendo Therapeutics Inc (MLND) stock worth over $15. Details can be seen in Chapman Paul W.d.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Chapman Paul W.d. has not made any transactions after 2016-05-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Chapman Paul W.d.

To

Chapman Paul W.d. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Chapman Paul W.d. owns 2 companies in total, including Millendo Therapeutics Inc (MLND) , and Tempest Therapeutics Inc (TPST) .

Click here to see the complete history of Chapman Paul W.d.’s form 4 insider trades.

Insider Ownership Summary of Chapman Paul W.d.

Ticker Comapny Transaction Date Type of Owner
MLND Millendo Therapeutics Inc 2016-05-10 Chief Operating Officer
TPST Tempest Therapeutics Inc 2016-03-03 Chief Operating Officer

Chapman Paul W.d. Latest Holdings Summary

Chapman Paul W.d. currently owns a total of 1 stock. Chapman Paul W.d. owns 14 shares of Millendo Therapeutics Inc (MLND) as of May 10, 2016, with a value of $15.

Latest Holdings of Chapman Paul W.d.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MLND Millendo Therapeutics Inc 2016-05-10 14 1.06 15

Holding Weightings of Chapman Paul W.d.


Chapman Paul W.d. Form 4 Trading Tracker

According to the SEC Form 4 filings, Chapman Paul W.d. has made a total of 0 transactions in Millendo Therapeutics Inc (MLND) over the past 5 years. The most-recent trade in Millendo Therapeutics Inc is the acquisition of 14 shares on May 10, 2016, which cost Chapman Paul W.d. around $22,847.

Insider Trading History of Chapman Paul W.d.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Chapman Paul W.d. Trading Performance

GuruFocus tracks the stock performance after each of Chapman Paul W.d.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Chapman Paul W.d. is -23.04%. GuruFocus also compares Chapman Paul W.d.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Chapman Paul W.d. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Chapman Paul W.d.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Chapman Paul W.d.

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -27.59 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -28.15 LIMIT LIMIT LIMIT LIMIT LIMIT

Chapman Paul W.d. Ownership Network

Ownership Network List of Chapman Paul W.d.

No Data

Ownership Network Relation of Chapman Paul W.d.

Insider Network Chart

Chapman Paul W.d. Owned Company Details

What does Millendo Therapeutics Inc do?

Who are the key executives at Millendo Therapeutics Inc?

Chapman Paul W.d. is the Chief Operating Officer of Millendo Therapeutics Inc. Other key executives at Millendo Therapeutics Inc include Chief Medical Officer Christophe Arbet-engels , Chief Development Officer Ryan Zeidan , and director & President and CEO Julia C. Owens .

Millendo Therapeutics Inc (MLND) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Millendo Therapeutics Inc (MLND) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Millendo Therapeutics Inc (MLND) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Millendo Therapeutics Inc (MLND)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Millendo Therapeutics Inc Insider Transactions

No Available Data

Chapman Paul W.d. Mailing Address

Above is the net worth, insider trading, and ownership report for Chapman Paul W.d.. You might contact Chapman Paul W.d. via mailing address: 215 First Street, Suite 240, Cambridge Ma 02142.

Discussions on Chapman Paul W.d.

No discussions yet.